TickerFactsScreenerDevelopers

ImmunityBio, Inc. (IBRX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2013: $3.0K2014: $235.0K2015: $2.24M2016: $6.56M2017: $34.81M2018: $13.10M2019: $4.29M2020: $1.67M2021: $33.56M2022: $78.16M2023: $30.58M2024: $6.89M2025: $3.85M$3.85M
2013Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$3.85M-44.2%
2024$6.89M-77.5%
2023$30.58M-60.9%
2022$78.16M+132.9%
2021$33.56M+1911.0%
2020$1.67M-61.1%
2019$4.29M-67.3%
2018$13.10M-62.4%
2017$34.81M+430.7%
2016$6.56M+192.7%
2015$2.24M+853.6%
2014$235.0K+7733.3%
2013$3.0K—